ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control and adding savory flavors are ways that ...
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Systematic review of bidirectional interaction between gut microbiome, miRNAs, and human pathologies
MicroRNAs (miRNAs) and the gut microbiome are key regulators of human health, with emerging evidence highlighting their complex, bidirectional interactions in chronic diseases. miRNAs, influence gene ...
In case a woman with bangs hasn’t already told you: Rilo Kiley are reuniting for Just Like Heaven 2025! The news first leaked via a billboard in LA a couple of weeks ago, and now it’s official ...
ChatGPT appears to consist of around 100 billion simulated neurons with around 1.75 trillion tunable variables ... behavior safely “aligns” with human values, researchers need to know how ...
This marks another milestone in the country's pursuit to develop homegrown technology for astronaut missions. The capsule that will one day ferry Indian astronauts to space and return them to ...
Discoveries in the past two decades have added new branches to the human family tree, including species such as the hobbit-like Homo floresiensis and the powerfully built Homo naledi. A pinkie ...
The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.
Sam Altman, pictured at President Donald Trump's inauguration, is contributing to another round of funding for Retro Biosciences. © 2025 Fortune Media IP Limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results